Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
April 14, 2023 16:35 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 14, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on April 13, 2023 from the Listing...
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
April 06, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 06, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
March 16, 2023 16:24 ET
|
Lifecore Biomedical, Inc.
Provides $10 million upfront cash commitment to Lifecore for infrastructure preparation and production capacity preparation Customer to provide reimbursement for up to $15 million in capital...
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
March 16, 2023 16:23 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
March 16, 2023 16:21 ET
|
Lifecore Biomedical, Inc.
Company Announces Intention to Explore Strategic AlternativesSigns Term Sheet with Key Customer to Materially Expand Commercial RelationshipExpands Development Pipeline from 24 to 25 Active Projects...
Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
February 07, 2023 16:30 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
January 11, 2023 16:35 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), announced today that it received a notice (“Notice”) on January 11, 2023 from the Listing...
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
January 09, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
$38.75 million Private Placement of Series A Convertible Preferred Stock to Support Working Capital and Capital Expenditures While Pursuing Ongoing Divestment Process of non-CDMO Assets Credit...
Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
November 25, 2022 16:50 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 25, 2022 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Announces Completion of Corporate Name Change
November 14, 2022 09:02 ET
|
Lifecore Biomedical, Inc.
Common stock expected to begin trading tomorrow under new Nasdaq ticker symbol “LFCR” Lifecore global headquarters relocated to Chaska, MN Launches new investor relations website: ir.lifecore.com ...